| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/15/2008 | CA2669127A1 Heterodimers of glutamic acid |
| 05/14/2008 | EP1920786A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 05/14/2008 | EP1919517A1 Radiolabelled nanoparticles |
| 05/14/2008 | EP1919516A2 Use of peptides for imaging blood clots |
| 05/14/2008 | EP1919515A2 F-18 peptides for pre targeted positron emission tomography imaging |
| 05/14/2008 | EP1463533B1 Radioactive ion |
| 05/14/2008 | EP0961591B1 Method to enhance tissue accumulation of radiolabeled compounds |
| 05/14/2008 | EP0783313B1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 05/14/2008 | CN101180400A Nanoparticles comprising rna ligands |
| 05/14/2008 | CN101180272A Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |
| 05/14/2008 | CN100387305C Application of 99Tcm-SytI-C2A labelled compound used in vulnerable scleratheroma plague development |
| 05/14/2008 | CN100387304C Application of 99Tcm-Syt I-C2A labelled compound as imaging agent used in detecting malignant tumour cell after chemical therapy |
| 05/13/2008 | US7373197 Methods and devices to expand applications of intraoperative radiation probes |
| 05/13/2008 | US7371877 Glycerol ester derivative |
| 05/13/2008 | US7371534 Reagent comprising dye, monoclonal antibody conjugated to quencher, and enzyme inhibitor; luminescent signal; sensitive, no washing |
| 05/13/2008 | US7371395 Vaccine formulations |
| 05/13/2008 | US7371364 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 05/08/2008 | WO2008052788A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation |
| 05/08/2008 | WO2008033561A3 Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins |
| 05/08/2008 | WO2008028116A3 Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test |
| 05/08/2008 | WO2008026040A3 68ga-labeled peptide-based radiopharmaceuticals |
| 05/08/2008 | WO2007049061A3 Conjugates of semaphorin peptides as imaging agents for cancer |
| 05/08/2008 | WO2005061009A3 Microparticles for microarterial imaging and radiotherapy |
| 05/08/2008 | US20080108840 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 05/08/2008 | US20080107690 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treating wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne |
| 05/08/2008 | US20080107605 From a clone comprising complete nucleotide sequence for the expression of the TSH |
| 05/08/2008 | US20080107599 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 05/08/2008 | US20080107598 Conjugating a chelator, ethylenedicysteine to a targeting ligand, glucosamine, deoxyglucose, metronidazole, annexin V, guanine or LHRH; and a metal ion of 99mTc, 68Ga, 188Re or 187Re |
| 05/08/2008 | US20080107597 Isolation of antibodies that cross-react and neutralize rankl originating from multiple species |
| 05/08/2008 | US20080107596 Breast cancer specific genes; a polynucleotide, a protein expressed by a polynucleotide, a polynucleotide capable of hybridizing under stringent conditions |
| 05/08/2008 | US20080107595 Anti-CCR5 antibody |
| 05/08/2008 | CA2667395A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, their derivatives and their use and processes for their preparation |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918305A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 05/07/2008 | EP1918303A2 method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 05/07/2008 | EP1917042A2 Use of fructose-based compounds for the diagnosis of cancer |
| 05/07/2008 | EP1917041A2 Use of fructose-based therapies for the treatment of cancer |
| 05/07/2008 | EP1467757B1 Use of antibodies against the muc18 antigen |
| 05/07/2008 | EP1360208B1 Method for the production of cytotoxic anti-cancer antibodies |
| 05/07/2008 | CN101172162A Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/06/2008 | US7368474 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection |
| 05/06/2008 | US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/02/2008 | WO2008052187A2 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | WO2008050255A2 Contrast agents for detecting prostate cancer |
| 05/02/2008 | WO2008049866A1 New chelating compound |
| 05/02/2008 | WO2008049644A1 Thymidine analogs for imaging |
| 05/02/2008 | WO2007112348A3 Prodrug composition |
| 05/02/2008 | WO2007095443A3 Gastrin releasing peptide compounds |
| 05/02/2008 | CA2667019A1 Antibodies and immunoconjugates and uses therefor |
| 05/01/2008 | US20080103481 Methods for Preventing Retropulsion of Concretions and Fragments During Lithotripsy |
| 05/01/2008 | US20080102029 Loadable Polymeric Particles For Enhanced Imaging In Clinical Applications And Methods Of Preparing And Using The Same |
| 05/01/2008 | US20080102028 converting 2,2-dimethyloxirane to 2-methoxyisobutanol, and converting 2-methoxyisobutanol to 2-methoxyisobutylisonitrile; used in the preparation of technetium (99mTc) Sestamibi |
| 05/01/2008 | US20080102027 Targer For B-Cell Disorders |
| 05/01/2008 | US20080102026 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 05/01/2008 | US20080101989 Methods, Compositions and Kits Pertaining to Analyte Determination |
| 04/30/2008 | WO2008053285A1 Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(i) tetrafluoroborate |
| 04/30/2008 | EP1916003A1 Thymidine analogs for imaging |
| 04/30/2008 | EP1915181A2 Novel hiv targets |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1208116B1 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 04/30/2008 | CN101168554A Method for preparing 18F-FLT |
| 04/30/2008 | CN101168067A Method for decreasing immune cell surface antigenic sites immunogenicity and use |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384480C Delivery system for nucleic acids |
| 04/29/2008 | US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/29/2008 | US7364737 Binding, neutralization respiratory syncytial virus antigen |
| 04/29/2008 | US7364719 Vasoregulating compounds and methods of their use |
| 04/29/2008 | CA2370532C Capsule seed |
| 04/29/2008 | CA2250485C Diagnostic agent for diabetes |
| 04/29/2008 | CA2230372C Quantitation of p97 to diagnose and monitor alzheimer's disease |
| 04/24/2008 | WO2008048322A1 Mouse models to study cachexia |
| 04/24/2008 | WO2008048288A2 Novel nanoparticles and use thereof |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047345A1 Dendrimeric platform for controlled release of drugs |
| 04/24/2008 | WO2008046493A2 Radioactive metal complexes comprising a tridentate complexing sequence |
| 04/24/2008 | WO2008046463A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
| 04/24/2008 | US20080095717 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 04/24/2008 | US20080095702 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 04/24/2008 | US20080095701 Diagnostic Compounds |
| 04/24/2008 | US20080095700 DR4 antibodies and uses thereof |
| 04/24/2008 | US20080095699 Imaging contrast agents using nanoparticles |
| 04/24/2008 | CA2666910A1 Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use |
| 04/24/2008 | CA2665528A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/23/2008 | EP1913959A1 Radioactive metal complexes comprising a tridentate complexing sequence |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 04/22/2008 | US7361342 Cancerous disease modifying antibodies |
| 04/22/2008 | US7361336 Administering antibody or a fragment thereof that binds to a human homolog of frizzled, to inhibit the proliferation of cancer cells |
| 04/22/2008 | CA2261902C Radiolabeled annexin conjugates whith hexose and a chelator |
| 04/17/2008 | WO2008045976A2 Compositions and methods for treating and diagnosing cancers |
| 04/17/2008 | WO2008045604A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089838 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 04/17/2008 | US20080089837 monoclonal antibodies directed to the antigen Platelet derived growth factor-alpha |
| 04/17/2008 | US20080089836 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography |